Filter by

  • Publication Year
  • Availability
  • Attachment
  • Collection Type
    See More
  • General Material Designation
    See More
  • Location
    See More
  • Language
Found 4 from your keywords: subject="Terlipressin"
cover
Safety and efficacy of continuous terlipressin infusion in HRS-AKI in a trans…
Comment Share
Reddy KR

Hepatorenal syndrome-acute kidney injury (HRS-AKI) is associated with significant morbidity and mortality. While liver transplantation is the definitive treatment, continuous terlipressin infusion for HRS-AKI may provide benefit and, as such, was assessed in a population composed of candidates for liver transplant (LT). Fifty hospitalized LT-eligible patients with HRS-AKI received a single bolu…

Edition
-
ISBN/ISSN
-
Collation
-
Series Title
-
Call Number
-
cover
Effectiveness and safety evaluation of terlipressin in the treatment of intes…
Comment Share
Wan X

The study was divided into two phases, in the exploratory phase, we retrospectively analyzed the clinical data of patients with intestinal paralysis treated with low-dose terlipressin and explored its efficacy. In the clinical research phase, we designed a prospective cohort study, patients with intestinal paralysis were categorized into terlipressin treatment group (low-dose terlipressin was …

Edition
-
ISBN/ISSN
-
Collation
-
Series Title
-
Call Number
-
cover
Comparative efficacy of terlipressin and norepinephrine for treatment of hepa…
Comment Share
Olson JC

The treatment of choice for hepatorenal syndrome-acute kidney injury (HRS-AKI) is vasoconstrictor therapy in combination with albumin, preferably norepinephrine or terlipressin as recommended by recent guidelines. In the absence of larger head-to-head trials comparing the efficacy of terlipressin and norepinephrine, meta-analysis of smaller studies can provide insights needed to understand the …

Edition
-
ISBN/ISSN
-
Collation
-
Series Title
-
Call Number
-
cover
Variceal bleeding in cirrhotic patients
Comment Share
Mallet M

Variceal bleeding is one of the major causes of death in cirrhotic patients. The management during the acute phase and the secondary prophylaxis is well defined. Recent recommendations (2015 Baveno VI expert consensus) are available and should be followed for an optimal management, which must be performed as an emergency in a liver or general intensive-care unit. It is based on the early admini…

Edition
-
ISBN/ISSN
-
Collation
-
Series Title
-
Call Number
-